- Opening date set for our new Plaistow venue
- Last chance to buy discounted tickets for Hysteria!
- Study shows link between higher levels of sex hormones and an increased risk of breast cancer
Opening date set for our new Plaistow venue
Following on from last week’s announcement that the East London Programme will now be holding additional sessions at an venue in Plaistow, I very am happy to let everyone know that it will open next week!
The first therapy sessions will take place on Thursday 1st August, with one-to-one reflexology and reiki sessions being held from 1.00pm to 4.30pm. A group yoga class will also take place. To book in for any of these sessions, or simply to find out more about our new Plaistow venue, please contact Anisah on 020 7830 2310 or email her on firstname.lastname@example.org.
We would like to thank the Given-Wilson Institute once again for all their help in establishing the additional location, and enabling women from East London to access our complementary therapies and support without having to travel across London.
Last chance to buy discounted tickets for Hysteria!
Cancerkin’s theatre evening in support of Breast Cancer Awareness Month will take place at the Hampstead Theatre on Monday 7th October 2013. Set in 1938 in Hampstead, Hysteria was written and directed by Terry Johnson and stars Antony Sher as Sigmund Freud. An acknowledged modern classic, this hilarious farce is not one to miss.
Tickets for the performance can be bought directly from Cancerkin and include a pre-play drinks reception. However, you only have until Friday 2nd August 2013 to secure tickets at our “early bird” price of £45, so if you are planning on attending do book soon!
More information and ticket order forms can be found on our website. Alternatively, you can contact Holly if you have any further queries or would like to book tickets. She can be reached on email@example.com or by calling 020 7830 2323.
A new infusion suite at the Finchley Memorial Hospital (FMH) is bringing cancer care closer to patients’ homes
The nurse-led service is a the result of a joint project between the Royal Free London NHS Foundation Trust and Barnet and Chase Farm Hospitals NHS Trust and means that some cancer patients can now receive chemotherapy infusions and supportive treatments in this purpose-designed unit instead of having to travel to the Royal Free, Barnet Hospital or Chase Farm Hospital.
All patients will continue to start their treatment at one of the three hospitals, but, where clinically appropriate, patients will be offered the choice of continuing their treatment at FMH if it is more convenient for them.
The first person to be treated at the new unit was Tithi Pandya, who was diagnosed with breast cancer in February. She spoke of how useful this suite was: “I was very impressed with the unit. It’s so new and clean, all the staff are warm and welcoming…
“It’s very convenient for me and saves me so much time – it takes me 45 minutes on the bus to Barnet Hospital, as opposed to a 15-minute walk to Finchley Memorial. That really helps me in terms of organising childcare as well.”
Anyone who is interested just needs to speak to one of their nurses or consultant when they next visit the hospital. For more information about other Royal Free clinics at FMH, please see the Royal Free website.
Study shows link between higher levels of sex hormones and an increased risk of breast cancer
Research published in The Lancet Oncology has found a link between higher levels of sex hormones and an increased risk of breast cancer in premenopausal women.
The scientists, based at the University of Oxford, brought together data on hormone levels in the blood from seven earlier studies. In total, data from approximately 760 premenopausal women with breast cancer and 1,700 premenopausal women without breast cancer was considered.
The study found that doubling the concentration of the female sex hormones (oestradiol and oestrone) or the male sex hormones (androstenedione, dehydroepiandrosterone and testosterone) increased the risk of breast cancer by between one-fifth and one-third.
Lead author Professor Tim Key, said: “This analysis combined the results from seven previous studies to provide enough data for us to focus on the association between hormone levels and the risk of breast cancer in women before the age of 50. The results demonstrate a link between higher overall levels of sex hormones and breast cancer in premenopausal women – although due to the large variation in hormone levels over the menstrual cycle these findings cannot be used now to classify the risk for individual women.
“While the link between higher levels of sex hormones and breast cancer is well established in older, postmenopausal women, it’s much less clear what effect hormones have on cancer risk in younger, premenopausal women.
“But from this study we can say there appears to be a link, which has important implications for understanding the biology of breast cancer and for planning future research. “
Hazel Nunn, head of health information at Cancer Research UK, said: “This is a fascinating piece of research which is helping us to understand more about the role of sex hormones and the effect might have on breast cancer. With 1 in 5 breast cancers now diagnosed in women under 50 it’s important that we find out as much as we can about what increases the risk for younger women. We don’t yet know why having higher levels of some sex hormones might increase a woman’s risk so further research is needed to investigate this link.”
For more information, please see Cancer Research UK.
Holly Lovering 25th July 2013